Last reviewed · How we verify

NCT05609071

Technology of Intracranial Pressure Estimation by Single-Channel EEG in Brain Disease

Status unknown Last updated 20 April 2023
What this trial tests

trial in Intracranial Pressure Increase in 10 participants. Status unknown.

Timeline
22 March 2022
Primary endpoint
28 February 2023
31 December 2024

Quick facts

Lead sponsorSeoul National University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment10
Start date22 March 2022
Primary completion28 February 2023
Estimated completion31 December 2024
Sites1 location across South Korea

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

18 and older, any sex, with Intracranial Pressure Increase or Brain Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

If intracranial pressure can be measured non-invasively using single-channel EEG, clinicians will be able to easily monitor changes in intracranial pressure in patients with brain diseases in the clinical setting. Therefore, a more efficient treatment plan can be established and the prognosis of patients with brain disease can be expected to improve in the long term.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Intracranial Pressure Increase

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05609071.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing